Related Experiment Video
Updated: Jan 16, 2026

Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients
Published on: December 18, 2016
Graph based link prediction for epilepsy drug discovery
Xiaolong Shi1, R Sundareswaran2, M Shanmugapriya3
1Institute of Computing Science and Technology, Guangzhou University, Guangzhou, 510006, China.
Abstract:
Epilepsy is one of the most prevalent neurological disorders, affecting approximately 23 million people in Asia alone. It is a disorder with severe social impacts and is going to progressively damage the brain. It encompasses a wide range of syndromes and each one of them differs significantly in treatment options. Seizures are the common symptom in all of them. Despite being one of the most researched clinical conditions, the exact mechanism is still unknown, and this poses challenges for coming up with an effective treatment mechanism. Understanding phytochemical-protein interactions, inspired by Ayurveda, offers a natural alternative for treating epilepsy, especially where conventional drugs face resistance and side effects. Traditional lab methods are costly and time-intensive, making graph-based computational approaches a powerful and scalable solution. Inspired by Ayurveda, we propose a computational framework to predict phytochemical-protein interactions for potential epilepsy treatment. We propose that the interaction can be modeled as a bipartite graph, where nodes represent phytochemicals and proteins and edges are represented by interactions. We employ Graph Neural Networks to capture both local and global information about the graph. Initially, the entire graph was trained using Graph Convolutional Networks (GCN), Graph Attention Network (GAT), and GraphSAGE. To enhance predictive performance, we then constructed one-hop enclosing subgraphs for both positive and negative samples and trained the same three models on this refined dataset. Our best-performing model achieved an accuracy of 0.9778, precision of 0.9574, F1-score of 0.9782, and ROC-AUC score of 0.9994.
More Related Videos
07:01Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...